Cardiome Pharma (CRME) CEO Janzen Leaves Company; Interim CEO Named
Tweet Send to a Friend
Cardiome Pharma Corp. (Nasdaq: CRME) announced that ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
